Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab

By Pickartz T.   Ringel F.   Wedde M.   Renz H.   Klein A.   von Neuhoff N.   Dreger P.   Kreuzer K.A.   Schmidt C.A.   Srock S.   Schoeler D.   Schriever F.  

Experimental Hematology, Vol. 29, Iss. 12, 2001-12 ,pp. : 1410-1416

Elsevier

Access to resources Recommend Favorite

Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival

By Rastellini C.   Salam A.   Kuddus R.   Aitouche A.   Subbotin V.   Braun M.   Leach R.   Peach R.   Fung J.J.   Starzl T.E.   Rao A.S.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1242-1243

Elsevier

Access to resources Recommend Favorite

Hapten-Induced Primary and Memory Humoral Responses Are Inhibited by the Infusion of Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab)

By Gonzalez-Stawinski G.V.   Yu P.B.   Love S.D.   Parker W.   Davis R.D.  

Clinical Immunology, Vol. 98, Iss. 2, 2001-02 ,pp. : 175-179

Academic Press

Access to resources Recommend Favorite

Synergism of CTLA4-IG and Anti-CD4 Monoclonal Antibody Treatment in a Rat Kidney Transplant Model

By Graser E.   Risch K.   Linsley P.S.   Hancock W.W.   Muller A.   Brock J.   Reinke P.   Kupiec-Weglinski J.W.   Volk H.D.   Lehmann M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1307-1309

Elsevier

Access to resources Recommend Favorite

Treatment of Multiple Sclerosis with Anti-CD4 Monoclonal Antibody A Preliminary Report on B-F5 in 21 Patients

By Racadot E.   Rumbach L.   Bataillard M.   Galmiche J.   Henlin J-L.   Truttmann M.   Herve P.   Wijdenes J.  

Journal of Autoimmunity, Vol. 6, Iss. 6, 1993-12 ,pp. : 771-786

Academic Press

Access to resources Recommend Favorite